Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00762580 · ClinicalTrials.gov registry record

Features to Predict Success With Nonoperative Treatment of Patients With Rotator Cuff Tears

A clinical trial, sponsored by Vanderbilt University.

Completed
Registry status
452
Enrollment target

NCT00762580: Completed study, sponsored by Vanderbilt University.

NCT00762580 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 452 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00762580 has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
452 participants
Enrollment target

Study Summary

The goal of this study is to find which patients will improve with the nonsurgical treatment of physical therapy for the treatment of rotator cuff tears.

Trial Details

FieldValue
Enrollment Target 452 participants
Start Date 2006-01
Est. Completion 2024-01-11
Vanderbilt University

430 total trials

What the finished NCT00762580 record still lists

NCT00762580 is an observational study that tracks outcomes without assigning an intervention. The registered 452 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00762580 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00762580 about?

NCT00762580 is a clinical study titled "Features to Predict Success With Nonoperative Treatment of Patients With Rotator Cuff Tears". The goal of this study is to find which patients will improve with the nonsurgical treatment of physical therapy for the treatment of rotator cuff tears.

What is the current status of trial NCT00762580?

This trial is currently completed. The enrollment target is 452 participants. The study started on 2006-01. Estimated completion is 2024-01-11.

Who is sponsoring clinical trial NCT00762580?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05676255 · 452 participants · Phase 2

    The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project

  • NCT05703178 · 452 participants · Phase 3

    Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia

  • NCT03460977 · 453 participants · Phase 1

    A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

  • NCT04708171 · 453 participants

    The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00762580, the US trial registry maintained by the National Library of Medicine. NCT00762580 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.